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Abstract
It is now recognized that astrocytes participate in synaptic communication through intimate interactions with neurons.
A principal mechanism is through the release of gliotransmitters (GTs) such as ATP, D-serine and most notably,
glutamate, in response to astrocytic calcium elevations. We and others have shown that amyloid-β (Aβ), the toxic
trigger for Alzheimer’s disease (AD), interacts with hippocampal α7 nicotinic acetylcholine receptors (nAChRs). Since
α7nAChRs are highly permeable to calcium and are expressed on hippocampal astrocytes, we investigated whether
Aβ could activate astrocytic α7nAChRs in hippocampal slices and induce GT glutamate release. We found that
biologically-relevant concentrations of Aβ1-42 elicited α7nAChR-dependent calcium elevations in hippocampal CA1
astrocytes and induced NMDAR-mediated slow inward currents (SICs) in CA1 neurons. In the Tg2576 AD mouse
model for Aβ over-production and accumulation, we found that spontaneous astrocytic calcium elevations were of
higher frequency compared to wildtype (WT). The frequency and kinetic parameters of AD mice SICs indicated
enhanced gliotransmission, possibly due to increased endogenous Aβ observed in this model. Activation of
α7nAChRs on WT astrocytes increased spontaneous inward currents on pyramidal neurons while α7nAChRs on
astrocytes of AD mice were abrogated. These findings suggest that, at an age that far precedes the emergence of
cognitive deficits and plaque deposition, this mouse model for AD-like amyloidosis exhibits augmented astrocytic
activity and glutamate GT release suggesting possible repercussions for preclinical AD hippocampal neural networks
that contribute to subsequent cognitive decline.
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Introduction
It is now recognized that astrocytes contribute significantly to
synaptic communication and, in concert with presynaptic and
postsynaptic neuronal elements, participate in the underlying
mechanisms of brain plasticity, learning and memory.
Astrocytes ensheath synapses and modulate synaptic function
through the release of gliotransmitters (GTs) such as ATP, D-
serine and glutamate [1-3] in response to elevations in
astrocytic intracellular Ca2+ ([Ca2+]i) [4]. The interaction between
neuronal neurotransmitter receptors and astrocytes [5] and the
subsequent release of GTs has been shown to be involved in
many processes including mediation of hippocampal long term
potentiation [6,7] and learning [8].
Modulation of synaptic transmission through astrocytic Ca2+-
dependent GT release can be induced by neuronal transmitters
that act upon astrocytic plasma membrane receptors. One
unexplored neuronal signal that could potentially impact
astrocyte to neuron communication is the Alzheimer’s disease
(AD) toxicant amyloid-beta (Aβ), since it has been
demonstrated that synaptic activity leads to increased
interstitial Aβ under normal physiological conditions [9]. Given
that alpha7 nicotinic acetylcholine receptors (α7nAChRs): 1)
bind Aβ and are activated with picomolar affinity [10-13], 2) are
ligand gated ionotropic receptors highly permeable to Ca2+ [14],
and 3) are functionally expressed on hippocampal astrocytes
[15,16], we investigated the effects of astrocytic α7nAChRs on
[Ca2+]i and GT release following exposure to Aβ and α7nAChR-
selective ligands, as well as evaluated astrocytic activity in a
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mouse model for AD-like amyloidosis to investigate astrocytic
activity and subsequent GT release at an age that considerably
precedes manifestation of cognitive impairment and plaque
formation.
In hippocampal slices from WT rats and mice, Aβ1-42 at
biologically-relevant concentrations elicited α7nAChR-
dependent [Ca2+]i elevations in hippocampal astrocytes that
varied between CA1 strata and induced GT release. In APP
mice, we found that spontaneous astrocytic [Ca2+]i elevations
were of higher frequency compared to wild type and that there
was increased GT glutamate release as measured by NMDAR-
mediated slow inward currents (SICs) recorded in hippocampal
principal cells. These findings also suggest that, in addition to
potential effects of aberrant Aβ production on the fidelity of
hippocampal synaptic transmission, a long term consequence
of Aβ over-production is perturbation of gliotransmission
fidelity.
Materials and Methods
All procedures were approved by Aston University Bioethics
committee, and carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986 and associated procedures.
Slice preparation
Horizontal slices of hippocampus were prepared from 6-23
day old male Wistar rats. Animals were anaesthetised with
isofurane and euthenised by cervical dislocation. After removal,
the brain was placed in ice cold modified artificial cerebrospinal
fluid (ACSF) of composition (mM) NaCl 126, NaHCO3 26, KCl
1, KH2PO4 1.25, MgSO4 5, CaCl2 1 and Glucose 10. Slices
were then maintained at room temperature (23-25°C) in this
solution for a recovery period of 1 hour before experimental
use.
The same protocols were used for preparation of
hippocampal slices from 10-28 day old Tg2576 mice and wild
type littermates. Animals were bred by mating heterozygous
Tg2576 males with C57Bl6/SJL (F1) females (Jackson
Laboratory).
Tail clips were routinely collected following brain removal and
sent for genotyping post experimentally (Transnetyx).
Solutions and chemicals
The standard recording ACSF used in this study was (in
mM): NaCl 126, NaHCO3 26, KCl 2.5, KH2PO4 1.25, MgSO4 1,
CaCl2 2 and Glucose 10, unless otherwise stated. As we [17]
and others have done previously in attempting to enhance
NMDA-R mediated current detection, whole cell voltage clamp
(V-Clamp) recordings were conducted in 0-Mg2+ at room
temperature, unless otherwise stated. Pharmacological
compounds were included in the ACSF as stated in text.
Chemicals were obtained from Sigma-Aldrich unless otherwise
stated. PNU282987, PNU 120596, CGP55845, CPCCOEt,
LY34195 and PPADS were obtained from Tocris. D-APV,
tetrodotoxin (TTX), SR95531, NBQX, MTEP,
methyllycaconitine (MLA) and α-bungarotoxin were obtained
from Ascent. Fura-2 AM and Sulforhodamine 101 (SR101)
were obtained from Invitrogen. Aβ1-42 and Aβ1-40 were obtained
from Bachem. Aβ1-42 stock solutions were prepared according
to the methods of Dineley (2001). Briefly, Aβ stock solutions
were prepared at 100 µM in 200 mM HEPES pH 8.5, aliquoted
and stored frozen at -70°C until further dilution in ACSF for
treatments. This preparation yields oligomeric Aβ with the
predominant forms being trimer and hexamer [18]. The drug
cocktail for isolation of astrocytic mediated effects was
composed of (in µM): SR95531 (20), NBQX (20), D-APV (50),
MTEP (10), CGP55845 (100), CPCCOEt (100), LY341495
(100) PPADS (100) and TTX (0.1). In this study Aβ application
was achieved by including in the perfusate.
Electrophysiology
The recording chamber and manipulators were mounted on
a moveable top plate platform (MP MTP-01, Scientifica). Patch
clamp recordings were made using pipettes (2-4MΩ) containing
an internal solution of composition (in mM): KMeSO4 120,
HEPES 10, EGTA 0.1, Na2ATP 4, GTP 0.5 (Adjusted to pH
7.3-7.4 with KOH, osmolarity 285-290 mOsm). Currents were
recorded using a Multiclamp 700B amplifier, digitized with a
Digidata 1440A and acquired and analysed using PClamp
(Molecular Devices). Voltage clamp recordings were made at
-60mV. Cells with ≥ 20% change in access resistance were
excluded. SICs were analysed using the Event Detection
protocols in the Clampfit routine of PClamp. As in our previous
studies, events were accepted as SICs if their amplitude was
>20pA and their time to peak (indicated as rise time in figures)
was >20ms [17,19,20]. Data was exported to Sigmaplot
(Jandel) for further analysis and plotting.
For ELISA, hippocampus and cortex were dissected from P4
and P14 mice from TG2576 litters. Tissue was weighed and
combined with 8 x the mass of ice cold Guanidine HCL (5M)l/
Tris HCL(50mM) pH 8.0. Tissue was ground using a hand held
homogeniser (Thermofisher Scientific) and stored on ice. The
homogenate was then mixed 1:20 with ice cold Dulbecco’s
phosphate buffered saline (Thermofisher Scientific) with 5%
BSA and 0.03% Tween-20, supplemented with Complete mini
protease inhibitor cocktail (Roche). The sample was then
centrifuged at 16000 X g for 20 minutes at 4C. The supernatant
was carefully removed and placed into a fresh microcentrifuge
tube on ice. Samples were analysed using the Human Aβ1-42
ELISA kit (Life Technologies) according to the manufacturer’s
instructions.
Fluorescence imaging
To enable comparisons of activity in different conditions in
the same astrocytes we used the ratiometric calcium indicator
dye Fura-2. Slices were loaded with Fura-2 AM (Molecular
Probes) after a post cutting recovery period of 1 hr. This was
done by incubating for ~50 min at 30°C with 5µM of the
indicator dye and 0.01% pluronic acid. Under these conditions,
astrocytes are preferentially loaded [17]. For astrocytic
identification, slices were also loaded with 1µM Sulforhodamine
101, according to in vitro methods of Kafitz et al. [21]. The
recording chamber and manipulators were mounted on a
motorized moveable bridge (Luigs and Neumann) and
fluorescence dyes were excited using an Optoscan
monochromator system, fitted to a Nikon FN1 upright
Aβ-α7nAChR Mediated Astrocyte Glutamate Release
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microscope; filter cubes for selective Fura-2 and SR101
imaging were obtained from Chroma . Images of slice areas of
444µm x 341µm were routinely acquired every 5s with a x20
objective lens (NA=0.8) using an ORCA ER CCD camera
(Hamamatsu) and analysed using Simple PCI software
(Hamamatsu). Only cells positive for the astrocytic marker
SR101 were included in the analyses.
Ratiometric calcium values over time for specific regions of
interest (ROIs) were exported and analysed using Sigmaplot
(Systat). The number of events during a recording was
determined by identifying events where amplitude exceeded 2
standard deviations of baseline variations. Results are
expressed as the mean of the number of events per minute for
each astrocyte. For determination of amplitude changes, the
absolute ratio increases in the different conditions in the same
cells were compared.
Statistics
All quantitative data in the text and figures are presented as
mean±s.e.m. unless otherwise stated. Significance was
calculated using multivariate ANOVA and unpaired or paired
Student’s t-test as appropriate. Kolmogorov-Smirnov tests were
used for population distribution comparisons. Statistical
significance in figures is indicated as: P<0.05 *, P<0.01 ** or
P<0.005 ***.
Results
We first determined the effect of Aβ1-42 bath application on
astrocytic activity whilst monitoring astrocytic [Ca2+]i transients
in rat hippocampal slices. Concentrations of Aβ1-42 were used
that are considered physiological (300pM) [22] in addition to
that which would be expected to occur in the pathology of early
AD (10nM) [23,24]. The ratiometric indicator Fura-2 was used
so that extended imaging of the same astrocytes could be
conducted whilst minimising confounding effects of bleaching.
Slices were co-loaded with SR101 to allow identification of
astrocytes loaded with Fura-2 [25] (Figure 1A). Analysis of
[Ca2+]i transients was restricted to SR101 positive cells.
Astrocytes displayed spontaneous transients in the presence of
TTX (0.044 ± 0.006 transients/min, n=115 astrocytes, 5
preparations) as reported previously for many brain areas,
including hippocampus [17,26,27]. Astrocytic activity was
increased by application of 300pM (0.087 ± 0.0085) and by
10nM Aβ1-42.(0.10 ± 0.009, n=115 astrocytes 5 preparations
P<0.005) (Figure 1A). Astrocytic responses to Aβ1-42 did not
follow a typical dose-response relationship, possibly due to
α7nAChR desensitization properties as previously described
[13,14]. Analysis of the effect in different CA1 strata showed
that Aβ1-42 caused increased activity throughout CA1, with a
greater effect being seen in stratum radiatum (175% increase
to 10nM) (Figure 1B) where astrocytes ensheath afferent
synapses [28]. The effect of Aβ1-42 was inhibited in the
presence of the α7nAChR-selective antagonist methyl-
lycaconitine (MLA) at 10nM (ctrl: 0.012 ± 0.017; Aβ1-42 0.098 ±
0.0089, n=5) (Figure 1C), indicating involvement of this
receptor. Bath application of Aβ1-40 did not lead to a significant
increase in astrocytic activity (Ctrl: 0.0743 ± 0.0092, 300pM:
0.0629 ± 0.0076,10nM: 0.0838 ± 0.01, n=105 astrocytes 3
preparations), supporting a specific action of the Aβ1-42 peptide,
and consistent with previous findings on Aβ–α7nAChR
interactions [10,11,13]. To isolate, and confirm direct astrocytic
location of the α7nAChR mediated effect we applied Aβ1-42 to
slices in the presence of antagonists to the major hippocampal
neurotransmitter receptors which might induce astrocytic [Ca2+]i
elevations (CPCCOEt, LY34195, MTEP, NBQX, D-APV,
SR95531, CGP55845 and PPADS). Under these conditions
Aβ1-42 still led to an increase in astrocytic activity, (ctrl: 0.052 ±
0.0071, 300pM Aβ1-42: 0.0652 ± 0.0083 10nM Aβ1-42: 0.083 ±
0.009, 113 astrocytes 5 preparations P<0.005), indicating that
Aβ1-42 directly acts on astrocytic α7nAChRs. To investigate
rapid agonist effects, Aβ1-42 was applied focally via a glass
micropipette to the CA1 area. 10nM Aβ1-42 induced rapid [Ca2+]i
elevations in astrocytes in the area of application, which were
inhibited by 100nM alpha bungarotoxin (Aβ1-42 ratio increase
0.11± 0.007; with α-Btx 0.035 ± 0.004, n=101 astrocytes, 4
preparations, P<0.0001) (Figure 1D).
To further investigate the mechanism and cellular action of
Aβ1-42, we used the α7nAChR selective positive allosteric
modulator PNU120596. Treatment with PNU120596 enhanced
the response of astrocytes to Aβ1-42 (Figure 2A,B), increasing
both astrocytic [Ca2+]i transient frequency (300pM: 0.054 ±
0.0098, 10nM: 0.0693 ± 0.0115, following PNU120596 300pM
0.082 ± 0.009 10nM: 0.11 ± 0.01, P<0.05, 102 astrocytes 3
preparations) (Figure 2A,B) and the ratio of the individual
[Ca2+]i elevations (Figure 2C) (10nM Aβ1-42: 0.038 ± 0.0273 R,
Aβ1-42 and PNU120596 0.064 ± 0.049. P<0.00001 K-S test).
Since it is well established that astrocytic [Ca2+]i elevations
can lead to GT release, [5,7,17,19,29], notably that of
glutamate, the increase in astrocyte activity by Aβ1-42 may
therefore also be predicted to cause an increase in slow inward
currents (SICs) in hippocampal principal cells. We tested this
mechanism by conducting patch clamp recordings from CA1
pyramidal neurons before and during Aβ1-42 wash on. Aβ1-42
application indeed induced SICs and led to an increase in their
frequency following 10nM Aβ1-42 exposure (0.49 ± 0.2 SICs/
min, n=6) compared to the preceding control period (0.065 ±
0.029 SICs/min, n=21, P<0.005). The induced increase was
inhibited by the α7nAChR antagonist MLA (0.05 ± 0.034, n=6)
(Figure 3), and blocked by 50∝M of the NMDA receptor
antagonist D-APV (n=4), indicating that Aβ1-42 acts at
α7nAChRs to result in astrocyte glutamate release that
subsequently activates NMDARs (data not shown).
If Aβ1-42 exposure acts to increase astrocytic activity, we next
asked what happens under conditions of chronic elevated Aβ in
vivo as is likely the case in AD. Evidence from previous studies
indicated that astrocytic activity is increased in an APP/PS1 AD
model [30]. We therefore addressed the specific contribution of
APP to astrocytic activity by using the Tg2576 AD mouse
model that expresses a mutant form of human APP (K670→N
and M671→L) resulting in Aβ overproduction and accumulation
with concomitant synaptic and learning deficits [31,32]. In
hippocampal slices from wild type littermates, addition of Aβ1-42
had similar effects to those observed in rat hippocampal slices,
with Aβ1-42 increasing astrocyte calcium transients (Ctrl: 0.091 ±
0.01, 300pM 0.143 ± 0.009, 10nM 0.236 ± 0.016, n=7
Aβ-α7nAChR Mediated Astrocyte Glutamate Release
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Figure 1.  Aβ1-42 induces astrocytic calcium elevations.  Center, image of hippocampal slice showing location of imaged CA1
area conducted in this study. A. Top left, Fluorescence image at 380nm of Fura-2 loaded slice. Middle image shows SR101 loading
of astrocytes in same region. Combined image at bottom identifies co-loaded astrocytes. 350/380nm Ratio fluorescence traces over
time for the circled astrocytes ‘a’ to ‘e’ are shown on the right, in control conditions, with 300pM Aβ1-42, and in the presence of 10nm
Aβ1-42. B. Bargraph of astrocytic calcium transient frequency under control condition (light grey) and in response to 300pm (grey) or
10nM Aβ1-42 (dark grey) in CA1 Strata Oriens, Pyramidale and Radiatum. Data normalized to spontaneous activity in ACSF. C.
Summary bargraph showing increased CA1astrocytic activity in response to Aβ1-42, which is inhibited by MLA and not affected by
Aβ1-40. D. Left, fluorescent ratio image of a region of the Stratum Radiatum in CA1, with 4 circled astrocytes. 350/380 Ratio
fluorescence traces from these astrocytes are shown to the right illustrating their response to focal 10nM Aβ1-42 application in the
absence and presence of 100nM α-Btx. Bargraph on the right summarises the results from 4 such experiments.
doi: 10.1371/journal.pone.0081828.g001
Aβ-α7nAChR Mediated Astrocyte Glutamate Release
PLOS ONE | www.plosone.org 4 November 2013 | Volume 8 | Issue 11 | e81828
preparations, P<0.001) (Figure 4A). In Tg2576 hippocampal
slices, spontaneous astrocytic activity was elevated compared
to wild type slices (Ctrl: 0.36 ± 0.028 vs. 0.091 ± 0.01, P<0.05).
In contrast to wild type, wash on of Aβ1-42 to hippocampal slices
from Tg2576 mice caused a significant decrease in calcium
transients (300pM 0.23 ± 0.16, 10nM 0.23 ± 0.018, n=3
preparations, P<0.001) (Figure 4B). This effect was consistent
across the CA1 hippocampal layers (Figure 4C). Since our
hippocampal slices originate from very young mice, we
confirmed that Aβ1-42 is aberrantly elevated in Tg2576. Thus,
we determined Aβ1-42 levels in the brains of WT and Tg2576
animals at ages corresponding to the slice experiments (P4
and P14) and found that Aβ1-42 was significantly elevated in
samples from Tg2576 (3.62 0.26pmoles/g, n=7) compared to
WT (0.71 0.014pmoles/g, n=7, p<0.00001). Since we used a
human Aβ1-42 ELISA, values in the WT represent background.
Although we cannot rule out the effects of chronic exposure to
additional products generated from APP processing on
astrocytic function (e.g., APP C-terminal fragments [33]), the
most parsimonious explanation of this and our imaging data
thus far is that enhanced mutant APP expression in vivo
resulting in aberrant Aβ production and accumulation, leads to
increased astrocytic activity and alters the way that astrocytes
subsequently respond to application of additional Aβ1-42.
Aβ-induced increases in astrocytic activity and consequent
astrocyte glutamate release might also be predicted to have an
Figure 2.  Aβ1-42-mediated astrocytic activation is α7nAChR mediated.  A. Fluorescence ratio image of CA1 loaded with
Fura-2AM indicating location of monitored astrocytes. Four astrocytes are circled, and ratio traces over time for these astrocytes are
plotted to the right in the presence of Aβ1-42, and the α7nAChR allosteric modulator PNU120596 B. Bargraph summarising astrocytic
activity frequency normalised to control ACSF. C. Cumulative distribution plot of calcium event ratio amplitude for 10nM Aβ1-42 with
and without the presence of PNU120596.
doi: 10.1371/journal.pone.0081828.g002
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effect on SIC generation. We therefore recorded SICs from
CA1 pyramidal neurons in slices from wild type and Tg2576
mice. Both genotypes exhibited SICs (Figure 5A); however,
consistent with elevated spontaneous astrocytic activity,
Tg2576 mice exhibited increased SIC frequency as well (0.16 ±
0.045 SICs/min, n=20; 0.34 ± 0.10 SICs/min, n=22, P<0.0001
K-S); possibly a result of α7 nAChR up-regulation previously
reported for this AD model [34,35]. In addition, the kinetic
properties of the recorded SICs also proved to be different in
that SICs in Tg2576 pyramidal neurons had both longer rise
times (182.11 ± 29.44ms, n=79 compared to 58.65 ± 8.24ms,
n=39; for Tg2576 and wild type, respectively P<0.00001 K-S)
and current duration (1047.01 ± 282.11ms, n=79 compared to
330.44 ± 66.41ms, n=39; for Tg2576 and wild type,
respectively, P<0.00001 K-S) though similar amplitudes (72.8 ±
8.26pA n=79, compared to 66.01 ± 11.45pA, n=39; for Tg2576
and wild type, respectively) culminating in Tg2576 CA1
pyramidal neuron SICs conferring a greater charge transfer
(40.96 ± 10.8.∝C, n=79) than wild type (8.85±1.9 µC, n=39,
P<0.0001 K-S) (Figure 5D). The observed differences in the
response of hippocampal astrocytes to Aβ1-42 application in
slices from wild type and Tg2576 mice may be an effect of in
vivo Aβ exposure on α7nAChR-mediated GT release pathway.
To more directly test this, we used a selective α7nAChR
agonist as a tool to induce astrocytic glutamate release and
resultant SICs. Patch-clamp recordings from wild type CA1
pyramidal neurons following perfusion of 30µM PNU 282987
resulted in an increase in SIC frequency (ctrl: 0.1379 ± 0.047
SICs/min, agonist: 0.29 ± 0.065 SICs/min n=7, P<0.05) (Figure
6) whilst in neurons recorded from Tg2576 hippocampus, the
agonist had no overall further effect on the already elevated
SIC frequency (ctrl: 0.275 ± 0.060 SICs/min, agonist: 0.265 ±
0.053 SICs/min n= 9,) (Figure 6B). In individual experiments
the difference was manifested by a general increase in WT SIC
frequency but a mixture of responses in Tg2576 slices
consistent with dysregulated [Ca2+]i – GT release pathways.
Discussion
In this study we demonstrate a role for Aβ having an impact
on hippocampal neurons via interaction with astrocytic
α7nAChR, a Ca2+-permeable ligand gated receptor.
Furthermore, we provide the first description of hippocampal
astrocyte dysfunction in anatomically intact acute slices from
the Tg2576 mouse model for AD-like amyloidosis. Since we
observed these alterations in hippocampal slices from very
young animals, our data suggest that hippocampal astrocytes
represent a particularly vulnerable target in AD prior to overt
deficits in hippocampal plasticity and cognition [34,36,37].
Aβ activates α7nAChRs at physiologically relevant
concentrations
Aβ binds and activates α7nAChRs at picomolar
concentrations [10,11,13,38,39]. Our previous work [13]
showed that picomolar concentrations of Aβ1-42 had agonist
effects on α7nAChRs expressed in Xenopus oocytes while at
higher (nanomolar) concentrations acted as an antagonist.
Subsequent studies by other groups stirred debate as some
confirmed agonist properties [22,39] whilst others found
antagonist effects [40,41]. Discrepancies may be partly
explained by the dynamic nature of Aβ and its structural
sensitivity to pH, osmolarity, temperature, and concentration,
since methods of preparation vary between groups and
aggregation status is not always confirmed; indeed different
effects due to concentration, and aggregation state have been
reported within some studies [12,13,18,22,39]. In the present
study we used a method which produces soluble oligomeric
Aβ1-42 predominantly comprised of hexamers [12,13,18,37].
We found that picomolar Aβ1-42 induced [Ca2+]i elevations in
hippocampal CA1 astrocytes, which were inhibited by an
α7nAChR-selective antagonist and enhanced by an α7nAChR-
specific positive allosteric modulator. Our results indicate that
bath application of α7nAChR ligands, including Aβ1-42, resulted
Figure 3.  Aβ1-42 elicits astrocytic GT glutamate release.  A. Patch clamp recording from CA1 pyramidal neuron showing
elicitation of SICs following Aβ1-42 wash on. SICs marked with asterisks. B. Summary bargraph of SIC frequency increase in
response to different concentrations of Aβ1-42 and their block by MLA.
doi: 10.1371/journal.pone.0081828.g003
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Figure 4.  Differential effect of Aβ1-42 on astrocyte responses in WT and Tg2576 hippocampal slices.  A. Top. Fura-2 340/380
ratio image of WT CA1 astrocytes. Below, red image of SR101 astrocyte loading of the same area with exemplar astrocytes ‘a’ to ‘c’
circled. Ratio traces from circled astrocytes are shown to the right in control ACSF, and with 300pM or 10nM Aβ1-42. B. Fura-2 ratio
image of Tg2576 CA1 with SR101 labelling illustrated below. Ratio traces for the circled astrocytes under control condition and
Aβ1-42 are shown to the right. C. Bargraphs summarising astrocytic transient frequency in CA1 strata from WT (left) and Tg2576
(right) mice, indicating an increased response to Aβ1-42 in WT but a reduction in Tg2576. D. Aβ1-42 levels in WT and TG2576 from
P4,P14 determined with ELISA.
doi: 10.1371/journal.pone.0081828.g004
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in activation of at least a subset of the α7nAChR receptor
population so that we were able to observe astrocyte
responses that continued over hundreds of seconds. Our
results are consistent with prolonged Aβ1-42-mediated [Ca2+]i
signals elicited by α7nAChR activation in astrocytes [16] and
presynaptic terminals [39] and likely also involve a contribution
from intracellular calcium release [15,42].
Focal application of Aβ resulted in direct and rapid increases
in astrocyte calcium consistent with a direct agonist, while bath
application did not usually result in rapid synchronised calcium
elevations but rather in an increase in frequency of astrocyte
calcium elevations. Because of the described desensitising
action of α7nAChRs it is intriguing that such a prolonged
increase is seen, however it must be noted that there is little
information on astrocyte α7nAChRs, or how rapidly they
recover from desensitisation. Alternatively, it may also be that
the low Aβ concentrations used in our preparation are able to
interact dynamically with the α7 nAChR over a prolonged
period, or that α7nAChR interaction with CICR (as shown in
culture by Sharma and Vijayraghavan [15]) results in
establishment of long lasting increase in calcium elevation
frequency.
In addition to their expression on primary neurons and
interneurons in the hippocampus [43], functional α7nAChRs
are also expressed on NG2+ glial cells [44]. While this could
potentially confound the deciphering of experimental results,
our approach of blocking action potential propagation and
utilizing neurotransmitter receptor antagonists to block
secondary effects of neuronal α7nAChR activation indicate that
there is direct astrocytic α7nAChR activation by Aβ1-42. In the
absence of antagonists the astrocytic response to Aβ1-42 was
greater, indicating either a component effect on presynaptic
α7nAChR leading to additional astrocytic excitation or that
α7nAChR induced GT release results in astrocytic paracrine
signalling that amplifies the Aβ1-42 effect. Both these scenarios
may be important for the pathological roles of astrocytes in AD.
There is currently great interest and debate surrounding the
relationship between astrocyte receptor activation, astrocytic
[Ca2+]i elevation and GT release. Some findings support the
interpretation that modifying Gq G-protein-coupled Ca2+ release
Figure 5.  Spontaneous gliotransmission is altered in Tg2576.  A. Patch clamp recording from a CA1 pyramidal neuron from a
WT littermate, illustrating spontaneous SIC incidence. Two exemplar SICs are shown expanded beneath. Also shown is a recording
from a Tg2576 hippocampal slice with expanded SICs illustrated beneath. B. Cumulative probability distributions of SIC parameters
frequency, rise time, duration and charge (Q) for WT (black lines) and Tg2576 (dark grey lines).
doi: 10.1371/journal.pone.0081828.g005
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fails to impinge upon synaptic transmission and LTP induction
[45] whilst others indicate that specific [Ca2+]i elevation patterns
caused by different agonists induce neuronal SICs which can
influence plasticity [46]. Astrocytes in some brain areas,
including hippocampus, also express ligand gated ion channels
such as NMDA and P2X receptors [47], as well as α7nAChRs
[15,16]. Activation of such channels at the negative astrocytic
resting membrane potential would be expected to create a
significant [Ca2+]i signal due to the favourable calcium
electrochemical gradient and the high Ca2+ permeability of
α7nAChRs. In this study we found that [Ca2+]i elevations were
increased following Aβ1-42 exposure and enhanced by the
action of an α7nAChR allosteric modulator PNU 120596.
Activation of the ligand gated ionotropic receptor α7nAChR
by Aβ1-42 as well as by specific α7nAChR agonists also resulted
in SICs. Therefore, in addition to G-protein coupled receptor
activation, astrocytic hippocampal ligand gated α7nAChR
activation also induces gliotransmission.
Astrocytic activity is dysregulated in an animal model
for AD
Recording SICs in CA1 neurons enabled us to determine
that the observed effects on astrocytic [Ca2+]i had effects on GT
release as well as additionally demonstrate that SICs were
different in Tg2576 compared to WT littermates that resulted in
enhanced impact of NMDA-mediated currents on CA1 neurons.
Interestingly, while Aβ1-42 increased [Ca2+]i transients in WT
mice, [Ca2+]i transient frequency was not further increased in
Tg2576 mice. Directly probing α7nAChR mediated astrocytic
gliotransmission demonstrated that this difference was also
reflected in α7 nAChR function since activation with a selective
α7nAChR agonist induced SICs in slices obtained from WT
littermates but not in Tg2576. This difference in the α7nAChR-
mediated GT pathway may reflect specific changes in
α7nAChR function or a multi-faceted dysregulation in GT
release regulation; the latter scenario being supported by the
observed increased spontaneous [Ca2+]i elevations and GT
release from Tg2576 astrocytes.
Our observation that astrocytic [Ca2+]i transient frequency in
Tg2576 mice was increased compared to WT littermates
agrees with in vivo astrocytic imaging studies on an APP/PS1
transgenic model of AD [30] in which spontaneous cortical
astrocytic [Ca2+]i transients and synchrony in the vicinity of
plaques was increased. Since we interrogated slices obtained
from APP mice at a much younger age suggests that soluble
Aβ also has effects on these parameters; although we cannot
rule out the contribution of additional APP metabolites [33].
Figure 6.  α7nAChR-mediated glutamate gliotransmission is abrogated in Tg2576.  A. Patch clamp recording from a WT
hippocampal CA1 neuron. Application of PNU 282987 induces SICs which are blocked by D-APV. B. Bargraphs summarising SIC
frequency in WT and Tg2576 hippocampal slices following PNU 282987 wash on.
doi: 10.1371/journal.pone.0081828.g006
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Importantly our study shows that Aβ1-42 levels are elevated in
the first two postnatal weeks, long before synaptic and
cognitive deficits can be detected [13,36,37] at 5-6 months and
coincide with insoluble Aβ1-42 deposition [48,49]. Thus,
increased [Ca2+]i transients in Tg2576 hippocampal astrocytes
indicates that astrocytic function can be affected during very
early disease processes.
Functional implications of astrocytic α7nAChRs
Our finding that Aβ1-42-α7nAChR interaction increases
astrocytic activity to induce glutamate gliotransmission has
several implications regarding our understanding of astrocyte-
neuron interaction in the hippocampus. Activation of
hippocampal α7nAChRs contributes to synaptic plasticity and
cognition [50-53], and it has been previously reported that
physiological levels of Aβ1-42, acting via α7nAChR receptors,
can enhance the induction of hippocampal LTP [22]. Our data,
together with the increasing realization of GT influence on
different forms of hippocampal synaptic plasticity [2,6,7], posits
a role for astrocytic α7nAChR-mediated GT release as a
potential physiologically relevant mechanism in hippocampal
synaptic plasticity, especially considering synaptic activity-
induced Aβ release [9].
In AD there is accumulation of Aβ in the brain leading to
cognitive impairment hypothesized to initially be due to
synaptic failure [54,55]. Within such a context, Aβ-mediated
dysregulation of gliotransmission would be expected to disrupt
the intermediary role of astrocytes in synaptic function, while
increased glutamate from enhanced gliotransmission might
also lead to increased excitability within the hippocampal
neural network. It has been proposed that elevated Aβ1-42
inhibits LTP induction by increasing extra-synaptic NR2B
subunit-containing NMDA receptors leading to aberrant ERK
MAPK activation [56]. Glutamate transporters and an increase
in extra-synaptic spillover were implicated, while selectively
inhibiting glutamate uptake mimicked the effects of Aβ1-42 on
extrasynaptic NMDA receptors and increased MAPK activation.
Since inhibiting glutamate transporters in the hippocampus
increases astrocytic glutamate release [57] via NR2B-
containing receptors and we previously showed that activation
of α7nAChRs by Aβ1-42 increases hippocampal ERK MAPK
activity [12,18]. Therefore, from our data, one might predict that
elements of the MAPK pathway may be recruited by Aβ via
astrocytic α7nAChR-induced gliotransmission in AD.
Interestingly, Tg2576 mice exhibit age-dependent cognitive
decline as measured in several behavioral paradigms, but most
notably in those requiring proper hippocampal MAPK function
which are also impaired in human AD [37,49,58,59]. In human
AD and mouse models of the disease, astrocytes are known to
become activated, participate in the brain inflammatory
response [60-62] and undergo morphological changes [63].
A contemporaneous study found that an α-BTx sensitive
Aβ1-42-α7nAChR interaction resulted in sustained glutamate
release from cultured astrocytes [64], and that ambient
glutamate levels, detected using in vivo microdialysis, were
α7nAChR dependent. Our study, focusing on the frequency
and kinetics of SICs which result from phasic astrocytic
glutamate release as a result of Aβ1-42-α7nAChR interaction,
provides insight into the dynamic mechanistic relationship
between Aβ and GT release in the anatomically intact
hippocampal slice.
It is striking that we observed such early changes in
astrocytic function in Tg2576, at an age at which cognitive and
synaptic function are unaltered since studies on 3-4 months-old
Tg2576 reported no synaptic or cognitive deficits [36,37]. Our
results therefore indicate that astrocyte dysfunction could be an
important player in preclinical AD. Thus, if possible, monitoring
early astrocyte [Ca2+]i activity and GT release could serve as an
important biomarker for AD and presage later AD-related
cognitive impairment. Our findings additionally identify
astrocytic α7nAChRs as potential therapeutic targets.
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